by In2Pharma | Jun 2, 2026 | News
Belgium An update has been shared about the implementation timeline and scope of the Stock Monitoring Tool (SMT). Based on the latest information, the implementation of the SMT will be postponed to a later date, which is yet to be determined. In addition, several...
by In2Pharma | Dec 18, 2025 | News
Belgium A Stock Monitoring Tool (SMT) will be implemented by the government. The goal of this tool is to anticipate and manage (un)availabilities of medicinal products for human use. A Royal Decree is being drafted and includes mandatory reporting: By MAHs, parallel...
by In2Pharma | Oct 10, 2024 | News
The Netherlands As of 25 October 2024, a new version of the notification form of the “Meldpunt geneesmiddelentekorten en -defecten” will become available. The new form will include the following changes: The addition of the option to adjust the period indication of a...
